ROBERT SPIEGEL
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
DIRECTOR
SOL BARER, SOL J. BARER, ISAAC BLECH, LEUTHNER A. BRIAN, KURT CONTI, ANDREW EINHORN, HERBERT J. FALECK, PRIYA JAMBHEKAR, BRIAN LEUTHNER, BRIAN A. LEUTHNER, JAMES LOUGHLIN, JAMES J. LOUGHLIN, R. LOCH MACDONALD, ROBERT LOCH MACDONALD, BERT MARCHIO, ALBERT N. MARCHIO II, R LOCH MCDONALD, CARL SORANNO, CARL J. SORANNO, CARL SORRANO
DIRECTOR
DIRECTOR
RONI APPEL, RONI A. APPEL, KEN A. BERLIN, KENNETH BERLIN, RICHARD BERMAN, VERED BISKER-LEIB, YUVAL CABILLY, FREDRICK COBB, IGOR GITELMAN, ROY GOLAN, MURRAY A. GOLDBERG, ANDRES GUTIERREZ, SAMIR KHLEIF, BRIDGET MARTELL, THOMAS MCKEARN, THOMAS L. MCKEARN, THOMAS MOORE, THOMAS A. MOORE, PINI ORBACH, JAMES PATTON, MARK J. ROSENBLUM, JOHN ROTHMAN, JOHN M. ROTHMAN, DAVID SIDRANSKY
DIRECTOR
RAMTIN AGAH, RAMTIN AGAH, M.D., SHAUN R. BAGAI, JOOST DE SCHUTTER, LEESA GENTRY, KLAUS HAMBUECHEN, KLAUS W. HAMBUECHEN, RON KOCAK, RONALD B. KOCAK, KIRSTEN ANGELA MACFARLANE, LAURENCE J. MARTON, LAURENCE J. MARTON, M.D., KAMRAN NAJMABADI, ANGELA GILL NELMS, FRANK RAHMANI, UNA S. RYAN, UNA S. RYAN, PH.D., UNA S, RYAN, PHD, ROBERT J. SPIEGEL, MARK VOLL, MARTA GAIA ZANCHI, PH.D., MARTA GAIA ZANCHI, PHD
DIRECTOR
NICHOLAS BACOPOULOS, JOHN BANHAM, SAMUEL BARKER, SAMUEL L. BARKER, AVRAHAM BEN-TZVI, JUDY CHIAO, KWANG FOCK CHONG, KENNETH FERGUSON, CHRISTOPHER HENNEY, CHRISTOPHER S. HENNEY, GREGORY HRADSKY, GREGORY T. HRADSKY, MARK H. KIRSCHBAUM, DAVID LAZAR, PAUL MCBARRON, DAVID NATAN, SPIRO ROMBOTIS, BRIAN SCHWARTZ, LLOYD SEMS, KIU CU SENG, ROBERT J. SPEIGEL, DANIEL K. SPIEGELMAN, DAVID U-PRICHARD, KARIN WALKER, KARIN L. WALKER, DATUK DR. DORIS WONG SING EE
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-11-14
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-05-02
D
OTHER HEALTH CARE
PHARMACEUTICAL PREPARATIONS [2834]
NO REVENUES
Equity
2024-01-26
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-10-18
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-04-06
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-11-03

